4.7 Letter

Value of MRI as a surrogate marker for PML in natalizumab long-term therapy

Journal

JOURNAL OF NEUROLOGY
Volume 259, Issue 8, Pages 1732-1733

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-012-6426-5

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available